Eledon Pharmaceuticals, Inc.

NASDAQ:ELDN

Biotechnology

Healthcare
$2.03 +2.84%

+$0.11 today

Market cap
$171.45M
Beta
0.97
P/E (TTM)
-5.5
EPS (TTM)
-$0.70
52W Low $1.35High $4.60

Volume 1.12M

Average 1.37M

ELDN Operating Margin

Operating income as a percentage of revenue, showing the profitability of core operations.

No reported Operating Margin figures are available to summarize.

Operating Margin history

Percent of revenue · from the income statement

No Operating Margin data reported for this period type.

Operating Margin vs competitors

How ELDN compares with its peers on the latest reported figures

ELDN Competitors Peer median
Operating Margin for ELDN and competitors
Company Period LTM level YoY 3-year change
PBYIPuma Biotechnology, Inc.LTM Mar 202613.0% -3.0 pp+5.9 pp
VNDAVanda Pharmaceuticals Inc.LTM Mar 2026-73.6% -35.9 pp-72.4 pp
EDITEditas Medicine, Inc.LTM Mar 2026-297.5% +428.9 pp+901.1 pp
VYGRVoyager Therapeutics, Inc.LTM Mar 2026-349.2% -197.1 pp-202.3 pp
ABEOAbeona Therapeutics Inc.LTM Mar 2026-637.9% —+2063.9 pp
TRDAEntrada Therapeutics, Inc.LTM Mar 2026-3109.3% -3111.7 pp—
HUMAHumacyte, Inc.LTM Mar 2026-5649.2% -4216.0 pp+132.7 pp
ELDNEledon Pharmaceuticals, Inc.FY2025— ——
ACHVAchieve Life Sciences, Inc.FY2025— ——
AVIRAtea Pharmaceuticals, Inc.FY2025— ——
ALLOAllogene Therapeutics, Inc.FY2025— ——
Peer median (excluding ELDN) -349.2%-116.5 pp+69.3 pp

Competitors are the stored peer set for ELDN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00000
Gross Profit00000
Gross Margin—————
Research & Development23.74M27.08M30.31M51.96M66.27M
Selling, General & Admin13.13M12.7M12.69M18.61M16.98M
Operating Expenses36.87M88.43M43M70.58M83.25M
Depreciation & Amortization195K373K374K359K313K
EBITDA(36.67M)(39.41M)(116.16M)(35.39M)(45.27M)
EBITDA Margin—————
Operating Income(36.87M)(88.43M)(43M)(70.58M)(83.25M)
Operating Margin—————
Interest Income00000
Interest Expense00000
Other Income / Expenses7K462K(73.54M)34.82M37.67M
Income Before Tax(36.86M)(87.97M)(116.54M)(35.75M)(45.58M)
Pre-Tax Margin—————
Income Tax Expense(2.35M)00431K35K
Net Income(34.51M)(87.97M)(116.54M)(36.18M)(45.62M)
Net Margin—————
EPS (Basic)(2.33)(6.16)(4.73)(0.75)(0.56)
EPS (Diluted)(2.33)(6.16)(4.73)(0.75)(0.56)
Weighted Avg Shares14.82M14.29M24.62M48.54M81.84M
Weighted Avg Shares (Diluted)14.82M14.29M24.62M48.54M81.84M

Eledon Pharmaceuticals, Inc.

NASDAQ:ELDN

Intrinsic Alpha fair value

Locked

Current Price

$2.03

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.